Patients with gout: an under-recognised group at high risk of COVID-19.
作者信息
Dalbeth Nicola, Robinson Philip C
机构信息
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.
University of Queensland Faculty of Medicine, Brisbane, QLD, Australia.
出版信息
Lancet Rheumatol. 2021 May;3(5):e317-e318. doi: 10.1016/S2665-9913(21)00073-4. Epub 2021 Mar 9.
Abstract
摘要
相似文献
1
Patients with gout: an under-recognised group at high risk of COVID-19.痛风患者：一个未被充分认识的新冠病毒高风险群体。
Lancet Rheumatol. 2021 May;3(5):e317-e318. doi: 10.1016/S2665-9913(21)00073-4. Epub 2021 Mar 9.
2
A profile of health status and demographics of aged care facility residents with gout.痛风老年护理机构居民的健康状况和人口统计学概况。
Australas J Ageing. 2020 Mar;39(1):e153-e161. doi: 10.1111/ajag.12716. Epub 2019 Aug 21.
3
4
Gout in solid organ transplantation: a challenging clinical problem.实体器官移植中的痛风：一个具有挑战性的临床问题。
Drugs. 2005;65(18):2593-611. doi: 10.2165/00003495-200565180-00004.
5
Compliance in gout patients.痛风患者的依从性。
Acta Reumatol Port. 2010 Oct-Dec;35(5):466-74.
6
Gout in the writings of eminent ancient Greek and Byzantine physicians.古希腊和拜占庭著名医生著作中的痛风
Acta Med Hist Adriat. 2011;9(1):83-8.
7
Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.痛风：关节及其他方面、流行病学、临床特征、治疗及合并症
Maturitas. 2014 Aug;78(4):245-51. doi: 10.1016/j.maturitas.2014.05.001. Epub 2014 May 14.
8
[Analysis of serum ferritin and high sensitive C reactive protein in patients with gout].痛风患者血清铁蛋白与高敏C反应蛋白分析
Wei Sheng Yan Jiu. 2017 Mar;46(2):232-236.
9
Association Between Gout and Injury Risk: A National Retrospective Cohort Study.痛风与损伤风险的关联：一项全国回顾性队列研究。
Int J Environ Res Public Health. 2020 May 23;17(10):3679. doi: 10.3390/ijerph17103679.
10
Colchicine induced rhabdomyolysis.秋水仙碱诱发横纹肌溶解症。
Postgrad Med J. 2001 Mar;77(905):191-2. doi: 10.1136/pmj.77.905.191.
引用本文的文献
1
Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions.社区参与式随机对照试验，以在美国两个有风湿条件的城市传播与 COVID-19 疫苗相关的信息，并提高黑人个体的接种率。
BMJ Open. 2024 Aug 24;14(8):e087918. doi: 10.1136/bmjopen-2024-087918.
2
Enrichment analysis and chromosomal distribution of gout susceptible loci identified by genome-wide association studies.全基因组关联研究鉴定出的痛风易感位点的富集分析及染色体分布
EXCLI J. 2023 Nov 14;22:1146-1154. doi: 10.17179/excli2023-6481. eCollection 2023.
3
Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study.痛风与接种疫苗人群中严重 SARS-CoV-2 感染的超额风险：一项基于普通人群的研究。
Arthritis Rheumatol. 2023 Jan;75(1):122-132. doi: 10.1002/art.42339. Epub 2022 Nov 30.
4
Gout management and outcomes during established COVID-19 pandemic in 2020-2021: a cross-sectional Internet survey.2020 - 2021年新冠疫情期间痛风的管理与结局：一项横断面网络调查
Ther Adv Musculoskelet Dis. 2022 May 13;14:1759720X221096381. doi: 10.1177/1759720X221096381. eCollection 2022.
5
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.秋水仙碱预防与 COVID-19 疫苗接种后痛风发作减少有关。
Ann Rheum Dis. 2022 Aug;81(8):1189-1193. doi: 10.1136/annrheumdis-2022-222199. Epub 2022 Mar 11.
6
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study.英国生物银行中痛风与新冠病毒疾病诊断及死亡风险：一项基于人群的研究
Lancet Rheumatol. 2022 Apr;4(4):e274-e281. doi: 10.1016/S2665-9913(21)00401-X. Epub 2022 Jan 28.
7
Women with gout and COVID-19-an unfortunate combination?痛风与新冠肺炎并存的女性——是不幸的组合？
Lancet Rheumatol. 2022 Apr;4(4):e233-e234. doi: 10.1016/S2665-9913(22)00026-1. Epub 2022 Jan 28.
8
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.SARS-CoV-2 感染与风湿性疾病 COVID-19 结局：系统文献回顾和荟萃分析。
Arthritis Rheumatol. 2022 May;74(5):766-775. doi: 10.1002/art.42030. Epub 2022 Mar 28.
本文引用的文献
1
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者 COVID-19 相关死亡的相关因素：来自 COVID-19 全球风湿病联盟医生报告登记处的结果。
Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498. Epub 2021 Jan 27.
2
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.美国风湿病学会在 COVID-19 大流行期间成人患者风湿病管理指南：第 3 版。
Arthritis Rheumatol. 2021 Feb;73(2):e1-e12. doi: 10.1002/art.41596. Epub 2020 Dec 5.
3
Gout management and outcomes during the COVID-19 pandemic: a cross-sectional internet survey.2019冠状病毒病大流行期间的痛风管理与结局：一项横断面网络调查
Ther Adv Musculoskelet Dis. 2020 Oct 14;12:1759720X20966124. doi: 10.1177/1759720X20966124. eCollection 2020.
4
Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.美国 COVID-19 死亡率的种族/民族差异随年龄变化的情况：一项横断面研究。
PLoS Med. 2020 Oct 20;17(10):e1003402. doi: 10.1371/journal.pmed.1003402. eCollection 2020 Oct.
5
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.EULAR 临时推荐意见：在 SARS-CoV-2 背景下管理风湿和肌肉骨骼疾病。
Ann Rheum Dis. 2020 Jul;79(7):851-858. doi: 10.1136/annrheumdis-2020-217877. Epub 2020 Jun 5.
7
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.在患有新冠肺炎、急性呼吸窘迫综合征和炎症反应过度的患者中使用高剂量阿那白滞素进行白细胞介素-1阻断：一项回顾性队列研究。
Lancet Rheumatol. 2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.
8
Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.2019冠状病毒病大流行期间风湿病患者的护理：亚太风湿病学联盟的立场声明
Int J Rheum Dis. 2020 Jun;23(6):717-722. doi: 10.1111/1756-185X.13863. Epub 2020 May 27.
Zotero 插件